Dr. Nicholas Harris
מחלקה:
Biotechnology Engineering
Education :
PhD 1990, Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel. “A study of the molecular basis of human p53 heterogeneity and expression of heterogeneous human p53 proteins”
MSc 1985, Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel. “p53 tumor antigen: reconstitution of expression and characterization in a non-producer cell line”
DipEd 1980, Department of Education, University of Glasgow, Scotland
BSc 1979 Department of Biochemistry, University of Stirling, Scotland Biochemistry (Hons)
Research Interests
- 1. Small molecule drugs and biological (peptide) drugs for the treatment of inflammatory diseases
Courses
- 1. Advanced Subjects in Cell Biology and Molecular Biology
- 2. Biochemistry 1 (laboratory)
- 3. Diagnostics (laboratory)
- 4. Immunology
- 5. Molecular and Cellular Basis of Disease
- 6. Molecular Biology (laboratory)
- 7. Protein and Peptide Technologies
Files
שם הקובץ
תאריך
סוג
Refereed Papers
Recent Publications
Harris N, et al 2014. Small Molecule Inhibitors of Protein Interactions with
Glycosaminoglycans (SMIGs), a Novel Class of Bioactive Agents with Anti-
Inflammatory Properties. Biochimical Biophysica Acta 1840, 245-254
Ezerzer C, Harris N, et al 2009. Chemokine receptor-derived peptides as
multi-target drug leads for the treatment of inflammatory diseases,
Peptides 30, 1296-1305
Ezerzer C, Harris N 2007. Physiological immunity or pathological
autoimmunity – A question of balance. Autoimmunity Reviews 6, 488-496
Academic Appointments
2011- Head of the MSc (Biotechnology) program, ORT Braude College
2010-2013 – Head of Deparmtment, Biotechnology Engineering, ORT Braude College
Teaching Experience
ORT Braude College
- Graduate Courses2010- Protein and Peptide Technologies2012- Molecular and Cellular Basis of Disease
(with Dr I. Kepten and Profs M.Grozovsky, L.Ore) - Undergraduate Courses2010-11 – Advanced Subjects in Cell and Molecular Biology2011- Immunology2012-13 – Diagnostics (laboratory)2013-14 – Biochemistry 1 (laboratory)
2013-14 – Molecular Biology (laboratory)
Professional Activities
2006-2010 Co-Founder and VP R&D, Symthera (ProtAgonists) Ltd, Weizmann Science Park, Ness Ziona, Israel. Privately
owned biopharmaceutical startup established to discover and develop peptide drugs for the treatment of inflammatory diseases
2000-2005 Co-Founder and VP R&D, Rimonyx Pharmaceuticals Ltd, Weizmann Science Park, Ness Ziona, Israel. Privately owned biopharmaceutical startup established to discover and develop small molecule drugs for the treatment of inflammatory diseases
1999-2000 Laboratory Manager, Blood and Bone Marrow Transplant Unit, Tel-Aviv Medical Center, Tel-Aviv, Israel
1997-1999 Laboratory Manager, Laboratory of Molecular Biology, Department of Gastroenterology, Tel-Aviv Medical Center
1995-1997 Senior Scientist, QBI Enterprises Ltd, Weizmann Science Park, Ness Ziona, Israel. Privately owned biopharmaceutical startup established to develop drugs for the treatment of retinopathy, myocardial ischemia and acute renal failure, consequences of oxidative stress